Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2007 2
2008 1
2009 3
2010 2
2011 2
2012 1
2013 3
2015 2
2017 2
2018 1
2019 4
2020 2
2021 1
2022 8
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab in refractory nephrotic syndrome.
Prytuła A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K. Prytuła A, et al. Among authors: ognjanovic m. Pediatr Nephrol. 2010 Mar;25(3):461-8. doi: 10.1007/s00467-009-1376-6. Epub 2009 Dec 23. Pediatr Nephrol. 2010. PMID: 20033225
Successful ABO and HLA incompatible kidney transplantation in children in the UK.
Hew EY, Kessaris N, Stojanovic J, Jones H, Christian M, Edwards A, Milford DV, Ognjanovic M, Shenoy M, Baker RJ, Marks SD. Hew EY, et al. Among authors: ognjanovic m. Pediatr Nephrol. 2023 Feb;38(2):529-535. doi: 10.1007/s00467-022-05583-5. Epub 2022 Jun 13. Pediatr Nephrol. 2023. PMID: 35695967 Free PMC article.
Design and preparation of proline, tryptophan and poly-l-lysine functionalized magnetic nanoparticles and their radiolabeling with 131I and 177Lu for potential theranostic use.
Mirković M, Milanović Z, Perić M, Vranješ-Đurić S, Ognjanović M, Antić B, Kuraica M, Krstić I, Kubovcikova M, Antal I, Sobotova R, Zavisova V, Jurikova A, Fabian M, Koneracka M. Mirković M, et al. Among authors: ognjanovic m. Int J Pharm. 2022 Nov 25;628:122288. doi: 10.1016/j.ijpharm.2022.122288. Epub 2022 Oct 14. Int J Pharm. 2022. PMID: 36252644
Synthesis, Characterization, and Therapeutic Efficacy of 177Lu-DMSA@SPIONs in Nanobrachytherapy of Solid Tumors.
Stanković D, Radović M, Stanković A, Mirković M, Vukadinović A, Mijović M, Milanović Z, Ognjanović M, Janković D, Antić B, Vranješ-Đurić S, Savić M, Prijović Ž. Stanković D, et al. Among authors: ognjanovic m. Pharmaceutics. 2023 Jul 13;15(7):1943. doi: 10.3390/pharmaceutics15071943. Pharmaceutics. 2023. PMID: 37514129 Free PMC article.
44 results